Tacrolimus
NDC Package 62250-666-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Tacrolimus is used with other medications to prevent rejection of a kidney, heart, or liver transplant. Marketed by Belcher Pharmaceuticals,llc, this product is identified by NDC 62250-666 and is authorized under FDA application ANDA206651.

Identification & Billing

NDC Package Code
62250-666-02
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
62250-666
11-Digit Billing Format
62250066602
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tacrolimus
Dosage Form
-
Usage Information
Tacrolimus is used with other medications to prevent rejection of a kidney, heart, or liver transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.

Regulatory & Marketing

Labeler Name
Belcher Pharmaceuticals,llc
FDA Application #
ANDA206651
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-25-2018
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62250-666-02 identifies a specific commercial package of 100 capsule in 1 bottle of Tacrolimus, labeled by Belcher Pharmaceuticals,llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Belcher Pharmaceuticals,llc on April 25, 2018. The current certification is valid through December 31, 2024.

What are the primary indications for this medication?

Tacrolimus is used with other medications to prevent rejection of a kidney, heart, or liver transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.

How is this Belcher Pharmaceuticals,llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62250066602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62250-666-02
11-Digit CMS (5-4-2)
62250-0666-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.